The proposed MRC-CONFAP call for health systems research networks seeks to support UK-Brazil partnerships working to identify research questioned focused on improving the health system and health care for vulnerable communities in Brazil. The UK-Brazil network must include at least two participating Brazilian State Funding Agencies (“FAP”) in Brazil and one UK partner.
Proposed research activities should aim to provide evidence to strengthen the Brazilian health system and improve health outcomes. The joint funders will award proposals for rigorous, high quality research that will:
- Generate evidence on how to strengthen the health system and improve health outcomes in Brazil.
- Inform the delivery of evidence-based interventions or structural changes
- Provide evidence that is of direct relevance to decision makers and users in the field.
The MRC will make up to £2.0m available for this scheme to fund the UK collaborators. The £2m made available by the UK funders will be matched with equivalent effort from the Brazilian FAPs, who will fund the Brazilian collaborators.
The deadline for applications is 26th September 2017. For more information, and to apply see here.
Research funding available for the economic and social value of health in the UK
Research funding for behavioural insights in health care – New call from the Health Foundation










BU academic publishes in online newspaper in Nepal
Final day of the ESRC Festival of Social Science
Using Art to enhance Research
Register now to attend the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
Portrait Concert featuring BU academic at L’Espace du Son Festival 2025, Brussels
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease